Amgen (AMGN)

EBITDA Growth

10.84%

TTM · Period ending:

AMGN logo

AMGN EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported10.84%
AMGN TTM EBITDA YoY % (41.18% → 10.84%)
High-resolution chart · PNG

AMGN ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Amgen EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
10.8372%
9.173%
26.6247%
22.6656%
34.6118%
26.6175%
-9.7629%
-9.0339%
-20.2929%
-15.2496%
21.6287%
19.4071%
22.291%
28.0385%
7.7284%
12.3755%
8.6337%
-12.5197%
-13.0809%
-14.4649%
-11.4973%
-0.2197%
2.8734%
1.8936%
0.6147%
1.0867%
-1.9405%
-1.3773%
-4.1695%
-2.8287%
0.21%
-1.3813%
-0.2747%
1.6373%
2.6181%
7.7209%
10.6263%
10.0241%
12.0472%
15.0561%
22.574%
23.1766%
27.8121%
25.2412%
16.5421%
22.7871%
15.5156%
14.3577%
16.587%
6.9427%
5.9161%
2.3849%
14.2628%
20.2313%
22.8522%
25.0218%
-7.0052%
-12.714%
-15.0861%
-16.9563%
-4.6296%
-1.1998%
0.3367%
2.039%
6.8819%
10.6526%
8.6528%
5.0279%
8.562%
3.8883%
5.1162%
-5.693%
-14.6083%
-17.8542%
-16.1738%
13.2416%
19.5377%
26.6598%
25.4175%
-0.0331%
13.6769%
18.2846%
22.7162%
54.6939%
22.7435%
20.7293%
22.698%
-63.7164%
-59.2244%
-59.7406%
-61.2347%
407.4749%
433.5194%
447.1231%
442.3516%
13.4361%
9.371%
9.5241%
10.7817%
13.225%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.